Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Masoprocol and Calcium Supplement

supplement:

Masoprocol

Research Papers that Mention the Interaction

We identified a set of reagents, nordihydroguaiaretic acid and various calmodulin inhibitors, that inhibits Ca2+ entry and blocks the voltage-operable current but leaves the non-voltage-gated current unaltered.
The American journal of physiology  •  1996  |  View Paper
Treatments given with NDGA result in the reduction of SCE, CA and increase of MI as well as RI, suggesting its protective action on human lymphocytes in vitro against the norgestrel induced genotoxic damage.
Toxicology in vitro : an international journal published in association with BIBRA  •  2006  |  View Paper
We investigated this activity and found that NDGA prevented the rise in intracellular calcium necessary for the apoptotic activation of cPLA(2).
Life sciences  •  2005  |  View Paper
Enhancements of IM by Ca2+ and AA were blocked by the lipoxygenase (LO) inhibitors nordihydroguaiaretic acid (NDGA; 1‐5 microM) and 5,8,11‐eicosatrynoic acid (ETI; 10 microM).
The Journal of physiology  •  1995  |  View Paper
When high calcium was applied in the presence of 100 microM NDGA , induction of potentiation in the dentate gyrus was blocked, while in CA1 there was an initial potentiation which was not maintained on return to control medium.
Neuroscience Letters  •  1988  |  View Paper
The results demonstrated that the intracranial pressure, water content, and sodium and calcium but not potassium content were significantly decreased in cerebral edema tissue but only 48 h after pretreatment with indomethacin (10 mg/kg), nordihydroguaiaretic acid (3 mg/kg) or their combination in half doses.
European journal of pharmacology  •  1987  |  View Paper